Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.36 +0.62 (+2.24%)
Official Closing Price Updated: 7:00 PM EDT, Jun 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,414,167
Open 27.95
Bid (Size) 28.36 (5)
Ask (Size) 28.39 (4)
Prev. Close 27.74
Today's Range 27.73 - 28.41
52wk Range 25.20 - 37.80
Shares Outstanding 5,606,688,356
Dividend Yield 5.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility. 
Via InvestorPlace
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
The U.S. Supreme Court supports pharmaceutical companies, led by AstraZeneca, in a lawsuit accusing them of funding terrorism in Iraq, dismissing a lower court's ruling and sending the case back for... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal

Performance

YTD
-4.61%
-4.61%
1 Month
+0.21%
+0.21%
3 Month
+3.39%
+3.39%
6 Month
-0.18%
-0.18%
1 Year
-23.12%
-23.12%

More News

Read More
UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
Via Benzinga
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
Via InvestorPlace
A patient’s story: Managing ulcerative colitis symptoms from diagnosis to treatment
Via Brandpoint
Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug
Via Investor's Business Daily
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Via The Motley Fool
7 Dividend Stocks to Buy Now: June 2024
Via InvestorPlace
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
Via The Motley Fool
3 No-Brainer Stocks to Buy for Under $100 Right Now
Via The Motley Fool
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
Via The Motley Fool
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Via Benzinga
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
Via Benzinga
Exposures Product Safety
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
Via Investor's Business Daily
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns
Via InvestorPlace
Supreme Court Upholds 2017 Tax On Foreign Profits For US Businesses
Via Benzinga
3 Underrated Dividend Stock Machines to Turbocharge Your Income
Via InvestorPlace
7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027
Via InvestorPlace
Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis
Via Benzinga
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Via Benzinga
Exposures COVID-19
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Via The Motley Fool
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
Via Benzinga
Exposures Product Safety
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.